PUBLICATION

Unveiling the role of RPS17 and SLC4A1 in diamond-Blackfan Anemia: A zebrafish-based study

Authors
Kim, K., Lee, H., Ahn, S., Kim, Y.H., Oh, C.K.
ID
ZDB-PUB-250228-7
Date
2025
Source
Blood cells, molecules & diseases   112: 102912102912 (Journal)
Registered Authors
Keywords
Diamond-Blackfan Anemia, RNA sequencing, RPS17, SLC4A1, Zebrafish
MeSH Terms
  • Erythropoiesis/genetics
  • Zebrafish Proteins*/genetics
  • Zebrafish Proteins*/metabolism
  • Disease Models, Animal
  • Anion Exchange Protein 1, Erythrocyte*/genetics
  • Anion Exchange Protein 1, Erythrocyte*/metabolism
  • Humans
  • Animals
  • Anemia, Diamond-Blackfan*/genetics
  • Anemia, Diamond-Blackfan*/metabolism
  • Anemia, Diamond-Blackfan*/pathology
  • Gene Knockdown Techniques
  • Ribosomal Proteins*/genetics
  • Ribosomal Proteins*/metabolism
  • Zebrafish/genetics
PubMed
40015014 Full text @ Blood Cells Mol. Dis.
Abstract
Diamond-Blackfan Anemia (DBA) is a rare congenital disorder characterized by macrocytic anemia, physical abnormalities, and growth delays. Although RPS19 mutations have been more extensively studied in DBA compared to other ribosomal protein genes, the pathological mechanisms of genes such as RPS17 remain largely unexplored. This study aimed to investigate the role of RPS17 haploinsufficiency in DBA, focusing on its downstream effects on erythropoiesis and the involvement of SLC4A1, a critical erythrocyte membrane protein essential for red blood cell stability. Transcriptomic analysis of publicly available RNA sequencing data from DBA patients revealed significant downregulation of SLC4A1 in RPS17-mutated cases. To validate these findings, we generated a zebrafish model of DBA by knocking down rps17 using morpholino injections. Zebrafish embryos with rps17 knockdown exhibited reduced erythropoiesis, impaired hemoglobin synthesis, consistent with DBA. Further analysis confirmed decreased slc4a1a expression in rps17-morphants. Independent knockdown of slc4a1a in zebrafish resulted in similar erythropoietic defects, highlighting its critical role in red blood cell membrane integrity and function. This study identifies slc4a1 as a key downstream target of RPS17 haploinsufficiency and provides novel insights into the molecular mechanisms of DBA. By establishing zebrafish as an effective in vivo model, this research offers potential therapeutic targets for treating DBA and related erythropoietic disorders.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping